TY - JOUR
T1 - Cingulate networks associated with gray matter loss in Parkinson's disease show high expression of cholinergic genes in the healthy brain
AU - Keo, Arlin
AU - Dzyubachyk, Oleh
AU - van der Grond, Jeroen
AU - Hafkemeijer, Anne
AU - van de Berg, Wilma D.J.
AU - van Hilten, Jacobus J.
AU - Reinders, Marcel J.T.
AU - Mahfouz, Ahmed
N1 - Funding Information:
We thank Dr. L. E. Jonkman for her critical insight on the manuscript. This research received funding from The Netherlands Technology Foundation (STW), as part of the STW Project 12721 (Genes in Space). Dr. O. Dzyubachyk received funding from The Dutch Research Council (NWO) project 17126 (3DOmics). Dr. W.D.J. van de Berg received funding from Alzheimer Netherlands and LECMA (ISAO #14536-LECMA #14797) to study transcriptome datasets in the context of Parkinson's and Alzheimer's disease and was financially supported by grants from Amsterdam Neuroscience, Dutch Research council (ZonMW), Stichting Parkinson Fonds, Alzheimer association, and the MJ Fox foundation and Rotary Aalsmeer-Uithoorn. Dr. Wilma van de Berg performed contract research and consultancy for Hoffmann-La Roche, Lysosomal Therapeutics, CHDR, and Cross beta Sciences and received research consumables from Hoffmann-La Roche and Prothena. Prof. J.J. van Hilten received grants from Alkemade-Keuls Foundation, Stichting Parkinson Fonds (Optimist Study), The Netherlands Organisation for Health Research and Development (#40-46000-98-101), The Netherlands Organisation for Scientific Research (#628.004.001), Hersenstichting, AbbVie, Hoffmann-La-Roche, Lundbeck, and Centre of Human Drug Research outside the submitted work. This work was partially supported by an NWO Gravitation project: BRAINSCAPES (024.004.012).
Funding Information:
We thank Dr. L. E. Jonkman for her critical insight on the manuscript. This research received funding from The Netherlands Technology Foundation (STW), as part of the STW Project 12721 (Genes in Space). Dr. O. Dzyubachyk received funding from The Dutch Research Council (NWO) project 17126 (3DOmics). Dr. W.D.J. van de Berg received funding from Alzheimer Netherlands and LECMA (ISAO #14536‐LECMA #14797) to study transcriptome datasets in the context of Parkinson's and Alzheimer's disease and was financially supported by grants from Amsterdam Neuroscience, Dutch Research council (ZonMW), Stichting Parkinson Fonds, Alzheimer association, and the MJ Fox foundation and Rotary Aalsmeer‐Uithoorn. Dr. Wilma van de Berg performed contract research and consultancy for Hoffmann‐La Roche, Lysosomal Therapeutics, CHDR, and Cross beta Sciences and received research consumables from Hoffmann‐La Roche and Prothena. Prof. J.J. van Hilten received grants from Alkemade‐Keuls Foundation, Stichting Parkinson Fonds (Optimist Study), The Netherlands Organisation for Health Research and Development (#40‐46000‐98‐101), The Netherlands Organisation for Scientific Research (#628.004.001), Hersenstichting, AbbVie, Hoffmann‐La‐Roche, Lundbeck, and Centre of Human Drug Research outside the submitted work. This work was partially supported by an NWO Gravitation project: BRAINSCAPES (024.004.012).
Publisher Copyright:
© 2021 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
PY - 2021/6
Y1 - 2021/6
N2 - Structural covariance networks are able to identify functionally organized brain regions by gray matter volume covariance across a population. We examined the transcriptomic signature of such anatomical networks in the healthy brain using postmortem microarray data from the Allen Human Brain Atlas. A previous study revealed that a posterior cingulate network and anterior cingulate network showed decreased gray matter in brains of Parkinson's disease patients. Therefore, we examined these two anatomical networks to understand the underlying molecular processes that may be involved in Parkinson's disease. Whole brain transcriptomics from the healthy brain revealed upregulation of genes associated with serotonin, GPCR, GABA, glutamate, and RAS-signaling pathways. Our results also suggest involvement of the cholinergic circuit, in which genes NPPA, SOSTDC1, and TYRP1 may play a functional role. Finally, both networks were enriched for genes associated with neuropsychiatric disorders that overlap with Parkinson's disease symptoms. The identified genes and pathways contribute to healthy functions of the posterior and anterior cingulate networks and disruptions to these functions may in turn contribute to the pathological and clinical events observed in Parkinson's disease.
AB - Structural covariance networks are able to identify functionally organized brain regions by gray matter volume covariance across a population. We examined the transcriptomic signature of such anatomical networks in the healthy brain using postmortem microarray data from the Allen Human Brain Atlas. A previous study revealed that a posterior cingulate network and anterior cingulate network showed decreased gray matter in brains of Parkinson's disease patients. Therefore, we examined these two anatomical networks to understand the underlying molecular processes that may be involved in Parkinson's disease. Whole brain transcriptomics from the healthy brain revealed upregulation of genes associated with serotonin, GPCR, GABA, glutamate, and RAS-signaling pathways. Our results also suggest involvement of the cholinergic circuit, in which genes NPPA, SOSTDC1, and TYRP1 may play a functional role. Finally, both networks were enriched for genes associated with neuropsychiatric disorders that overlap with Parkinson's disease symptoms. The identified genes and pathways contribute to healthy functions of the posterior and anterior cingulate networks and disruptions to these functions may in turn contribute to the pathological and clinical events observed in Parkinson's disease.
KW - Allen Human Brain Atlas
KW - brain imaging
KW - neuroinformatics
KW - spatial transcriptomics
KW - structural covariance networks
UR - https://www.scopus.com/pages/publications/85104338098
UR - https://www.ncbi.nlm.nih.gov/pubmed/33792979
U2 - 10.1111/ejn.15216
DO - 10.1111/ejn.15216
M3 - Article
C2 - 33792979
SN - 0953-816X
VL - 53
SP - 3727
EP - 3739
JO - European journal of neuroscience
JF - European journal of neuroscience
IS - 11
ER -